ES2325413T3 - Composiciones farmaceuticas basadas en nk2 antagonistas para uso pediatrico. - Google Patents

Composiciones farmaceuticas basadas en nk2 antagonistas para uso pediatrico. Download PDF

Info

Publication number
ES2325413T3
ES2325413T3 ES05810894T ES05810894T ES2325413T3 ES 2325413 T3 ES2325413 T3 ES 2325413T3 ES 05810894 T ES05810894 T ES 05810894T ES 05810894 T ES05810894 T ES 05810894T ES 2325413 T3 ES2325413 T3 ES 2325413T3
Authority
ES
Spain
Prior art keywords
antagonist
tachiquinin
antagonists
pharmaceutical compositions
pediatric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05810894T
Other languages
English (en)
Spanish (es)
Inventor
Alberto c/o LABORATORI GUIDOTTI S.P.A. ALEOTTI
Maria Altamura
Carlo Alberto Maggi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorio Guidotti SpA
Original Assignee
Laboratorio Guidotti SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorio Guidotti SpA filed Critical Laboratorio Guidotti SpA
Application granted granted Critical
Publication of ES2325413T3 publication Critical patent/ES2325413T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
ES05810894T 2004-10-27 2005-10-26 Composiciones farmaceuticas basadas en nk2 antagonistas para uso pediatrico. Expired - Lifetime ES2325413T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITFI04A0221 2004-10-27
IT000221A ITFI20040221A1 (it) 2004-10-27 2004-10-27 Composizioni farmaceutiche a base di nk2 antagonisti per uso pediatrico

Publications (1)

Publication Number Publication Date
ES2325413T3 true ES2325413T3 (es) 2009-09-03

Family

ID=35613882

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05810894T Expired - Lifetime ES2325413T3 (es) 2004-10-27 2005-10-26 Composiciones farmaceuticas basadas en nk2 antagonistas para uso pediatrico.

Country Status (25)

Country Link
US (2) US7727955B2 (enExample)
EP (1) EP1809267B1 (enExample)
JP (1) JP2008517977A (enExample)
CN (1) CN101052386A (enExample)
AR (1) AR051595A1 (enExample)
AT (1) ATE422881T1 (enExample)
AU (1) AU2005298629B2 (enExample)
CA (1) CA2584481C (enExample)
CY (1) CY1109803T1 (enExample)
DE (1) DE602005012857D1 (enExample)
DK (1) DK1809267T3 (enExample)
EA (1) EA012264B1 (enExample)
ES (1) ES2325413T3 (enExample)
HR (1) HRP20090225T1 (enExample)
IT (1) ITFI20040221A1 (enExample)
MX (1) MX2007004461A (enExample)
NO (1) NO338586B1 (enExample)
NZ (1) NZ555380A (enExample)
PL (1) PL1809267T3 (enExample)
PT (1) PT1809267E (enExample)
RS (1) RS50780B (enExample)
SI (1) SI1809267T1 (enExample)
UA (1) UA91988C2 (enExample)
WO (1) WO2006045820A1 (enExample)
ZA (1) ZA200703909B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0614970D0 (en) * 2006-07-27 2006-09-06 R & D Sosei Ltd Compounds For Use In Therapy
IT1394304B1 (it) * 2009-05-21 2012-06-06 Malesci Sas Processo per la preparazione di ibodutant (men15596) e relativi intermedi
ITRM20120331A1 (it) * 2012-07-12 2014-01-13 Guidotti & C Spa Labor Composizioni pediatriche orali liquide contenenti nepadutant.
US20160051596A1 (en) * 2014-08-21 2016-02-25 Food Industry Research And Development Institute Novel acetobacter and gluconacetobacter strains and their metabolites for use in inhibiting xanthine oxidase
US9867857B2 (en) 2014-08-21 2018-01-16 Food Industry Research And Development Institute Acetobacter and gluconacetobacter strains and their metabolites for use in inhibiting xanthine oxidase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0219318A (ja) * 1988-06-30 1990-01-23 Carl R Thornfeldt 疝痛及び生歯に対する治療
IT1277835B1 (it) * 1995-03-13 1997-11-12 Menarini Farma Ind Composti biciclici, loro preparazione ed uso in composizioni farmaceutiche
IT1307809B1 (it) * 1999-10-21 2001-11-19 Menarini Ricerche Spa Composti monociclici basici ad azione nk-2 antagonista, processi difabbricazione e formulazioni che li contengono.
MY130373A (en) * 2001-10-29 2007-06-29 Malesci Sas Linear basic compounds having nk-2 antagonist activity and formulations thereof
GB0224788D0 (en) * 2002-10-24 2002-12-04 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
NO20072720L (no) 2007-07-09
US20080090795A1 (en) 2008-04-17
CN101052386A (zh) 2007-10-10
EA200700949A1 (ru) 2007-10-26
ITFI20040221A1 (it) 2005-01-27
ATE422881T1 (de) 2009-03-15
NO338586B1 (no) 2016-09-12
HRP20090225T1 (hr) 2009-05-31
EP1809267B1 (en) 2009-02-18
RS50780B (sr) 2010-08-31
CY1109803T1 (el) 2014-09-10
EP1809267A1 (en) 2007-07-25
PT1809267E (pt) 2009-05-28
DE602005012857D1 (de) 2009-04-02
SI1809267T1 (sl) 2009-06-30
AU2005298629B2 (en) 2011-02-17
MX2007004461A (es) 2007-07-11
ZA200703909B (en) 2008-09-25
UA91988C2 (ru) 2010-09-27
DK1809267T3 (da) 2009-05-18
CA2584481C (en) 2014-07-15
AU2005298629A1 (en) 2006-05-04
PL1809267T3 (pl) 2009-07-31
US20100234284A1 (en) 2010-09-16
HK1109335A1 (en) 2008-06-06
US7727955B2 (en) 2010-06-01
WO2006045820A1 (en) 2006-05-04
JP2008517977A (ja) 2008-05-29
EA012264B1 (ru) 2009-08-28
NZ555380A (en) 2008-12-24
CA2584481A1 (en) 2006-05-04
AR051595A1 (es) 2007-01-24

Similar Documents

Publication Publication Date Title
ES2702848T3 (es) Complejos de flumazenil, composiciones que los comprenden y usos de los mismos
KR20060130175A (ko) 미다졸람을 고농도로 포함하는 제약학적 조성물
ES2617252T3 (es) Solución oral que comprende clorhidrato de atomoxetina
US20190209530A1 (en) Powder oral suspension formulations of antibacterial agents
US9326935B2 (en) Atomoxetine solution
KR100753879B1 (ko) 체온 상승성 아미노산군 음식용 제제
ES2325413T3 (es) Composiciones farmaceuticas basadas en nk2 antagonistas para uso pediatrico.
CZ20013735A3 (cs) Perorální roztok prucalopridu
US9421268B2 (en) Pediatric oral liquid compositions containing nepadutant
ES2470333T3 (es) Composiciones y métodos para aumentar los niveles de plaquetas de la sangre en humanos
AU2020311624B2 (en) Stable oral composition of cyclophosphamide
US20220273646A1 (en) Pharmaceutical composition of temozolomide
HK1109335B (en) Pharmaceutical compositions based on nk2 antagonists for pediatric use
ES2866961T3 (es) Medicamento oral que comprende un laxante osmótico incorporado en una matriz basada en materias grasas vegetales
JP6826695B2 (ja) 医薬組成物
JP2006507266A (ja) 性的機能不全を処置するための組成物および方法
OA17358A (en) Pediatric oral liquid compositions containing nepadutant.